Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 74.44% is in line with its 5-year average of 73.36%, around the middle of its 5-year range (68.88%–77.61%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.83% below its 12-month average of 75.06%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 74.47%.
GROSS MARGIN
74.44%
GROSS MARGIN AVG TTM
75.06%
GROSS MARGIN AVG 3Y
74.84%
GROSS MARGIN AVG 5Y
73.36%
GROSS MARGIN AVG 10Y
70.69%
GROSS MARGIN AVG 15Y
69.48%
GROSS MARGIN AVG 20Y
70.16%
CURRENT VS TTM AVG
-0.83%
CURRENT VS 3Y AVG
-0.54%
CURRENT VS 5Y AVG
+1.47%
CURRENT VS 10Y AVG
+5.31%
CURRENT VS 15Y AVG
+7.13%
CURRENT VS 20Y AVG
+6.10%
SECTOR MEDIAN · HEALTHCARE
59.92%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+24.22%
vs the sector median at left
Market Cap
$242.11B
Gross Margin
41.03%
TTM Avg
41.14%
3Y Avg
41.18%
5Y Avg
44.09%
Market Cap
$332.94B
Gross Margin
73.73%
TTM Avg
73.81%
3Y Avg
73.64%
5Y Avg
72.52%
Market Cap
$337.74B
Gross Margin
22.49%
TTM Avg
20.43%
3Y Avg
22.48%
5Y Avg
23.36%
Market Cap
$179.47B
Gross Margin
79.59%
TTM Avg
78.55%
3Y Avg
78.10%
5Y Avg
78.28%
Market Cap
$168.71B
Gross Margin
56.80%
TTM Avg
53.17%
3Y Avg
51.86%
5Y Avg
51.92%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novartis AG (NVS) | $268.00B | 74.44% | 75.06% | 74.84% | 73.36% |
| AstraZeneca PLC (AZN)vs › | $243.33B | 81.88% | 81.51% | 79.26% | 77.31% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $242.11B | 41.03% | 41.14% | 41.18% | 44.09% |
| Amgen Inc. (AMGN)vs › | $217.52B | 72.65% | 66.16% | 69.53% | 71.51% |
| Roche Holding AG (RHHBY)vs › | $332.94B | 73.73% | 73.81% | 73.64% | 72.52% |
| UnitedHealth Group Incorporated (UNH)vs › | $337.74B | 22.49% | 20.43% | 22.48% | 23.36% |
| Merck & Co., Inc. (MRK)vs › | $356.40B | 75.38% | 74.15% | 73.03% | 71.89% |
| Gilead Sciences, Inc. (GILD)vs › | $179.47B | 79.59% | 78.55% | 78.10% | 78.28% |
| Abbott Laboratories (ABT)vs › | $168.71B | 56.80% | 53.17% | 51.86% | 51.92% |
| Novo Nordisk A/S (NVO)vs › | $165.72B | 80.64% | 82.83% | 83.54% | 83.48% |
Gross Margin
74.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 74.47% |
| 2026-03-31 | 74.42% |
| 2025-12-31 | 73.44% |
| 2025-09-29 | 75.35% |
| 2025-06-30 | 77.61% |
| 2025-03-31 | 76.31% |
| 2024-12-31 | 75.48% |
| 2024-09-30 | 75.45% |
| 2024-06-30 | 75.35% |
| 2024-03-31 | 74.46% |
| 2023-12-31 | 74.34% |
| 2023-09-30 | 74.22% |
| 2023-06-30 | 71.55% |
| 2023-03-31 | 72.92% |
| 2022-12-31 | 68.88% |
| 2022-09-30 | 73.35% |
| 2022-06-30 | 71.33% |
| 2022-03-31 | 69.91% |
| 2021-12-31 | 70.60% |
| 2021-09-30 | 70.54% |
| 2021-06-30 | 70.56% |
| 2021-03-31 | 68.18% |
| 2020-12-31 | 67.64% |
| 2020-09-30 | 70.07% |
| 2020-06-30 | 70.50% |
| 2020-03-31 | 70.71% |
| 2019-12-31 | 68.61% |
| 2019-09-30 | 69.75% |
| 2019-06-30 | 71.67% |
| 2019-03-31 | 71.62% |
| 2018-12-31 | 63.95% |
| 2018-09-30 | 69.59% |
| 2018-06-30 | 69.47% |
| 2018-03-31 | 69.09% |
| 2017-12-31 | 65.90% |
| 2017-09-30 | 65.94% |
| 2017-06-30 | 65.92% |
| 2017-03-31 | 65.17% |
| 2016-12-31 | 64.39% |
| 2016-09-30 | 64.61% |
| 2016-06-30 | 64.89% |
| 2016-03-31 | 64.34% |
| 2015-12-31 | 64.47% |
| 2015-09-30 | 64.85% |
| 2015-06-30 | 65.21% |
| 2015-03-31 | 67.38% |
| 2014-12-31 | 66.93% |
| 2014-09-30 | 66.76% |
| 2014-06-30 | 68.61% |
| 2014-03-31 | 68.31% |
| 2013-12-31 | 65.42% |
| 2013-09-30 | 68.03% |
| 2013-06-30 | 69.22% |
| 2013-03-31 | 67.58% |
| 2012-12-31 | 66.24% |
| 2012-09-30 | 67.41% |
| 2012-06-30 | 68.30% |
| 2012-03-31 | 67.77% |
| 2011-12-31 | 65.87% |
| 2011-09-30 | 68.15% |
| 2011-06-30 | 69.46% |
| 2011-03-31 | 68.65% |
| 2010-12-31 | 68.72% |
| 2010-09-30 | 71.44% |
| 2010-06-30 | 73.11% |
| 2010-03-31 | 74.94% |
| 2009-12-31 | 72.10% |
| 2009-09-30 | 72.52% |
| 2009-06-30 | 73.71% |
| 2009-03-31 | 71.71% |
| 2008-12-31 | 72.61% |
| 2008-09-30 | 72.61% |
| 2008-06-30 | 73.28% |
| 2008-03-31 | 74.08% |
| 2007-12-31 | 70.38% |
| 2007-09-30 | 69.10% |
| 2007-06-30 | 73.44% |
| 2007-03-31 | 73.46% |
| 2006-12-31 | 73.02% |
| 2006-09-30 | 71.97% |
| 2006-06-30 | 73.85% |
| 2006-03-31 | 73.23% |
| 2005-12-31 | 71.24% |
| 2005-09-30 | 71.14% |
| 2005-06-30 | 74.90% |
| 2005-03-31 | 74.76% |
| 2004-12-31 | 75.16% |
| 2004-09-30 | 77.14% |
| 2004-06-30 | 77.14% |
| 2004-03-31 | 76.86% |
| 2003-12-31 | 76.11% |
| 2003-09-30 | 75.85% |
| 2003-06-30 | 77.06% |
| 2003-03-31 | 76.18% |
| 2002-12-31 | 77.45% |
| 2002-09-30 | 76.06% |
